Health Condition 1: N920- Excessive and frequent menstruation with regular cycle
Conditions
Interventions
None listed
Sponsors
Dr Soumya Benachanamardi
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of age group 16 - 40 years 2.Patients with excessive and prolonged bleeding p/v during menstruation 3.Patient willing to sign Consent form
Exclusion criteria
Exclusion criteria: 1.Hb% below 8gms 2.Patient using Intra uterine contraceptive devices 3.Known cases of Hypertension, Diabetes mellitus, Malignancy, Tuberculosis or any uncontrolled severe systematic disorders and metabolic disorders 4.Known cases of Coagulation disorders 5.Known cases of any pelvic pathology (e.g.Uterine fibroid, Pelvic inflammatory disease) 6.Any other illness reseacher feels that interfere the inyervention of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of Trial drug on improvement of classical symptoms of Raktapradara (Dysfunctional Uterine Bleeding)Timepoint: 5 Days - Starting fron 5th day of menstruation for 5 days X 2 consecutive cycles Follow up - 10th of Menstruation | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of the Trial drug and adverse drug reaction and aggravation in symptoms of Raktapradara(Dysfunctional Uterine Bleeding)Timepoint: 5 Days - Starting fron 5th day of menstruation for 5 days X 2 consecutive cycles Follow up - 10th of Menstruation | — |
Countries
India
Contacts
Public ContactDr Soumya Benachanamardi
SDMTs ayurvedic college and hospital terdal
Outcome results
None listed